Leveraging its close relationship with local PRC firm Shanghai Pacific Legal, Norton Rose Fulbright's Hong Kong-based Greater China IP team covers the full spectrum of IP litigation and transactional work in China. Practice head Justin Davidson has a strong record advising both multinational and Chinese businesses on a wide range of contentious and non-contentious IP issues, including those in the financial services, tech, manufacturing, pharmaceuticals and fashion sectors.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is able to provide comprehensive and practical solutions in trademark, patent, trade secret, and copyrights issues.'

  • ‘Justin Davidson is very familiar with IP protection in Hong Kong and China and is able to provide clients with tailored and practical solutions.'

Key clients

  • BNP Paribas
  • A.Y. Laboratories Ltd
  • Antisense Therapeutics Limited
  • Commonwealth Scientific and Industrial Research Organisation
  • De Motu Cordis Pty Ltd
  • Endogene Limited
  • Genus plc
  • Integrated Protein Technologies, Inc.
  • Neuren Pharmaceuticals Limited
  • Stembiosys. Inc.
  • University of Louisville Research Foundation Inc.
  • Crown Worldwide Holdings Ltd.
  • Global Futures & Options
  • ASTRI (Applied Science and Technology Research Institute)
  • City University
  • WaveTouch Limited
  • Stella McCartney Ltd

Work highlights

  • Advising Crown Worldwide on the protection and enforcement of their IP portfolio.
  • Advised Dell on a number of patent litigations in mainland China.
  • Advising WaveTouch on a patent litigation case in China and Germany concerning optical fingerprint technology.

Practice head

The lawyer(s) leading their teams.

Justin Davidson

Other key lawyers

Stanley Ng